Evidence map›Paper›PMID 23333589›Full record

ArticleExperimental neurology2014

Fractalkine signaling and Tau hyper-phosphorylation are associated with autophagic alterations in lentiviral Tau and Aβ1-42 gene transfer models.

Michaeline L Hebron, Norah K Algarzae, Irina Lonskaya, Charbel Moussa

Abstract read
In one paragraph

Article in Experimental neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Inflammatory-Mediated Neuron-Glia Communication Modulates ALS Pathophysiology.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Gene Therapy Models of Alzheimer's Disease and Other Dementias.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michaeline L HebronDepartment of Neuroscience, Georgetown University Medical Center, Washington D.C. 20007, USA; Department of Biochemistry and Cell Biology, Georgetown University Medical Center, Washington D.C. 20007, USA.
Norah K AlgarzaeDepartment of Neuroscience, Georgetown University Medical Center, Washington D.C. 20007, USA; Department of Biochemistry and Cell Biology, Georgetown University Medical Center, Washington D.C. 20007, USA.
Irina LonskayaDepartment of Neuroscience, Georgetown University Medical Center, Washington D.C. 20007, USA.
Charbel MoussaDepartment of Neuroscience, Georgetown University Medical Center, Washington D.C. 20007, USA. Electronic address: cem46@georgetown.edu.
Georgetown University · USGeorgetown University Medical Center · US

Funding

Parkin protection in gene transfer animal models (KO-1 Award)K01AG030378 · NIA · GEORGETOWN UNIVERSITY · PI MOUSSA, CHARBEL · 2008 to 2012
$607k
NIA NIH HHS AG30378NIA NIH HHS K01 AG030378
6 · The paper itself

Abstract

Tau hyper-phosphorylation (p-Tau) and neuro-inflammation are hallmarks of neurodegeneration. Previous findings suggest that microglial activation via CX3CL1 promotes p-Tau. We examined inflammation and autophagic p-Tau clearance in lentiviral Tau and mutant P301L expressing rats and used lentiviral Aβ1-42 to induce p-Tau. Lentiviral Tau or P301L expression significantly increased caspase-3 activity and TNF-α, but CX3CL1 was significantly higher in animals expressing Tau compared to P301L. Lentiviral Aβ1-42 induced p-Tau 4 weeks post-injection, and increased caspase-3 activation (8-fold) and TNF-α levels. Increased levels of ADAM-10/17 were also detected with p-Tau. IL-6 levels were increased but CX3CL1 did not change in the absence of p-Tau (2 weeks); however, p-Tau reversed these effects, which were associated with increased microglial activity. We observed changes in autophagic markers, including accumulation of autophagic vacuoles (AVs) and p-Tau accumulation in autophagosomes but not lysosomes, suggesting alteration of autophagy. Taken together, microglial activation may promote p-Tau independent of total Tau levels via CX3CL1 signaling, which seems to depend on interaction with inflammatory markers, mainly IL-6. The simultaneous change in autophagy and CX3CL1 signaling suggests communication between microglia and neurons, raising the possibility that accumulation of intraneuronal amyloid, due to lack of autophagic clearance, may lead microglia activation to promote p-Tau as a tag for phagocytic degradation.

Indexed as

Amyloid beta-PeptidesAnimalsAutophagyCaspase 3Cerebral CortexChemokine CX3CL1CytokinesGene Expression RegulationGene Transfer TechniquesGlial Fibrillary Acidic ProteinLentivirusMaleMicrogliaMutationPeptide FragmentsPhosphorylationAmyloid beta-Peptidesamyloid beta-protein (1-42)Caspase 3Chemokine CX3CL1Cx3cl1 protein, ratCytokinesGlial Fibrillary Acidic ProteinPeptide Fragmentstau ProteinsAutophagosomeAutophagyCX3CL1InflammationTau phosphorylation

Identifiers

PMID23333589
PMCPMC3644355
OpenAlexW1999506942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.